TCG Labs Soleil’s Juri Biosciences is offering EpimAb Biotherapeutics up to $210 million biobucks for exclusive licensing ...

Indian CDMOs are strategically expanding through acquisitions in the US and Europe, driven by global pharma's nearshoring ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...

With the goal to become a top 3 pharma company in China, Novartis has been busy tapping into the expertise of local ...

China's Livzon Pharmaceutical Group Inc. will spend VND5.73 trillion ($221 million) to acquire almost 65 per cent of ...

As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...

Pfizer PFE announced that it is in-licensing global development and commercialization rights, ex-China, to SSGJ-707, a bispecific antibody targeting PD-1 and VEGF, from Chinese biotech, 3SBio. 3SBio ...

China and Hong Kong shares fell on Friday, weighed down by losses in the auto sector amid increased regulatory and consumer ...

ORI Capital is planning a US$350 million fund to focus on Chinese biotech, with hopes that AI will help beat the market.

L’Oréal Groupe has backed Chinese biotech start-up Veminsyn to help identify new ingredients and speed up the process of ...

With Illumina currently banned from shipping its DNA sequencers into China—in retaliation for the Trump administration’s ...

Hong Kong stocks capped a sixth straight weekly gain on optimism that a de-escalation in US-China tensions will dispel the ...